Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
LP-10 in Refractory Hemorrhagic Cystitis
NCT03129126Phase 2Completed
- Sponsor
- Lipella Pharmaceuticals
- Start
- Oct 2020
- Primary completion
- Aug 2023
- Modality
- Targeted Liposomes, Stealth (PEGylated) Liposomes, Conventional Liposomes
- Countries
- 1
01
Overview
A Phase 2 trial of liposomal tacrolimus in hemorrhagic cystitis (HC), sponsored by Lipella Pharmaceuticals. Started Oct 2020; status: completed.
02
Drugs
liposomal tacrolimus
03
Conditions
hemorrhagic cystitis (HC)
Beyond the preview
Go deeper on NCT03129126.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03129126.